Hyperexcitability to sulphonylurea in MODY3.
Søvik
O
O
Njølstad
P
P
Følling
I
I
Sagen
J
J
Cockburn
B N
BN
Bell
G I
GI
D002675:Child, Preschool; D004268:DNA-Binding Proteins; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000235:genetics; D004342:Drug Hypersensitivity / Q000209:etiology*; D005192:Family Health; D005260:Female; D051537:Hepatocyte Nuclear Factor 1; D051538:Hepatocyte Nuclear Factor 1-alpha; D051539:Hepatocyte Nuclear Factor 1-beta; D006801:Humans; D008297:Male; D009154:Mutation / Q000235:genetics; D009664:Norway / Q000453:epidemiology; D009687:Nuclear Proteins; D010375:Pedigree; D013453:Sulfonylurea Compounds / Q000009:adverse effects*; D014157:Transcription Factors / Q000235:genetics*
D004268:DNA-Binding Proteins; C496487:HNF1A protein, human; C496495:HNF1B protein, human; D051538:Hepatocyte Nuclear Factor 1-alpha; D009687:Nuclear Proteins; D013453:Sulfonylurea Compounds; D014157:Transcription Factors; D051537:Hepatocyte Nuclear Factor 1; D051539:Hepatocyte Nuclear Factor 1-beta